A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

Clinical trial NCT07024173 · RECRUITING

Trial details

NCT number: NCT07024173
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2025-07-23
Primary completion: 2026-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.